1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Hepáticas y Digestivas

Enfermedades Hepáticas y Digestivas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Salcedo M, Prieto M, Castells L, Pascasio JM, Alvarez JLM, Fernández I, Sánchez-Antolín G, González-Diéguez L, García-Gonzalez M, Otero A, Lorente S, Espinosa MD, Testillano M, González A, Castellote J, Casafont F, Londoño MC, Pons JA, Molina Pérez E, Cuervas-Mons V, Pascual S, Herrero JI, Narváez I, Vinaixa C, Llaneras J, Sousa JM, Bañares R.

    Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.

    TRANSPLANT INTERNATIONAL . 30(10): 1041-1050. Nº de citas: 7

    [doi:10.1111/tri.12999]

  • Martín-Llahí M, Albillos A, Bañares R, Berzigotti A, García-Criado MÁ, Genescà J, Hernández-Gea V, Llop-Herrera E, Masnou-Ridaura H, Mateo J, Navascués CA, Puente Á, Romero-Gutiérrez M, Simón-Talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-Pagán JC.

    Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

    GASTROENTEROLOGIA Y HEPATOLOGIA . 40(8): 538-580. Nº de citas: 13

    [doi:10.1016/j.gastrohep.2017.03.011]

  • Albillos A, Zamora J, Martínez J, Arroyo D, Ahmad I, De-la-Peña J, Garcia-Pagán JC, Lo GH, Sarin S, Sharma B, Abraldes J, Bosch J, Garcia-Tsao G, Baveno cooperation.

    Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.

    HEPATOLOGY . 66(4): 1219-1231. Nº de citas: 43

    [doi:10.1002/hep.29267]

  • Tavio-Hernandez E, Vazquez-Sequeiros E, Rodriguez-Santiago E, Gonzalez-Martin JA, Foruny-Olcina JR, Benita-Leon V, Defarges-Pons V, Boixeda-Miquel D, Albillos-Martínez A.

    What Is the Value of the Learning Curve in Endoscopic Balloon Dilatation of the Major Papilla?

    GASTROENT RES PRACT . 2017: 6501485-6501485.

    [doi:10.1155/2017/6501485]

  • Domènech E, López-Sanromán A, Nos P, Vera M, Chaparro M, Esteve M, Gisbert JP, Mañosa M, en representación de GETECCU..

    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.

    GASTROENTEROLOGIA Y HEPATOLOGIA . 40(7): 472-483. Nº de citas: 16

    [doi:10.1016/j.gastrohep.2017.05.005]

  • Rodríguez de Lope C, Reig M, Matilla A, Ferrer MT, Dueñas E, Mínguez B, F Castroagudín J, Ortiz I, Pascual S, Lledó JL, Gallego A, Arenas JI, Aracil C, Forne M, Muñoz C, Pons F, Sala M, Iñarrairaegui M, Martin-Llahi M, Andreu V, Garre C, Rendón P, Fuentes J, Crespo J, Rodríguez M, Bruix J, Varela M.

    Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.

    MEDICINA CLINICA . 149(2): 61-71. Nº de citas: 12

    [doi:10.1016/j.medcli.2016.12.048]

  • García García de Paredes A, Teruel Sánchez-Vegazo C, Hernanz Ruiz N, Ferre Aracil C, Rodríguez de Santiago E, Aguilera Castro L, Sierra Morales M, Albillos A.

    Do patients with iron deficiency without anemia benefit from an endoscopic examination?

    J DIGEST DIS . 18(7): 416-424. Nº de citas: 5

    [doi:10.1111/1751-2980.12495]

  • Iborra M, Gisbert JP, Bosca-Watts MM, López-García A, García-Sánchez V, López-Sanromán A, Hinojosa E, Márquez L, García-López S, Chaparro M, Aceituno M, Calafat M, Guardiola J, Belloc B, Ber Y, Bujanda L, Beltrán B, Rodríguez-Gutiérrez C, Barrio J, Cabriada JL, Rivero M, Camargo R, van Domselaar M, Villoria A, Schuterman HS, Hervás D, Nos P.

    Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

    JOURNAL OF GASTROENTEROLOGY . 52(7): 875-877. Nº de citas: 1

    [doi:10.1007/s00535-016-1293-y]

  • Iborra M, Pérez-Gisbert J, Bosca-Watts MM, López-García A, García-Sánchez V, López-Sanromán A, Hinojosa E, Márquez L, García-López S, Chaparro M, Aceituno M, Calafat M, Guardiola J, Belloc B, Ber Y, Bujanda L, Beltrán B, Rodríguez-Gutiérrez C, Barrio J, Cabriada JL, Rivero M, Camargo R, van Domselaar M, Villoria A, Schuterman HS, Hervás D, Nos P.

    Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

    JOURNAL OF GASTROENTEROLOGY . 52(7): 788-799. Nº de citas: 38

    [doi:10.1007/s00535-016-1274-1]

  • Argüelles-Arias F, Carpio D, Calvet X, Romero C, Cea-Calvo L, Juliá B, López-Sanromán A.

    Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . 109(6): 421-429. Nº de citas: 4

    [doi:10.17235/reed.2017.4748/2016]

  • Crespo J, Calleja JL, Fernández I, Sacristan B, Ruiz-Antorán B, Ampuero J, Hernández-Conde M, García-Samaniego J, Gea F, Buti M, Cabezas J, Lens S, Morillas RM, Salcines JR, Pascasio JM, Turnes J, Sáez-Royuela F, Arenas J, Rincón D, Prieto M, Jorquera F, Sanchez Ruano JJ, Navascués CA, Molina E, Moya AG, Moreno-Planas JM.

    Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection.

    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY . 15(6): . Nº de citas: 22

    [doi:10.1016/j.cgh.2017.02.020]

  • Fernández Carrillo C, Lens S, Llop E, Pascasio JM, Crespo J, Arenas J, Fernández I, Baliellas C, Carrión JA, de la Mata M, Buti M, Castells L, Albillos A, Romero M, Turnes J, Pons C, Moreno-Planas JM, Moreno-Palomares JJ, Fernández-Rodriguez C, García-Samaniego J, Prieto M, Fernández Bermejo M, Salmerón J, Badia E, Salcedo M, Herrero JI, Granados R, Blé M, Mariño Z, Calleja JL.

    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

    HEPATOLOGY . 65(6): 1810-1822. Nº de citas: 55

    [doi:10.1002/hep.29097]

  • Calleja JL, Crespo J, Rincón D, Ruiz-Antorán B, Fernandez I, Perelló C, Gea F, Lens S, García-Samaniego J, Sacristán B, García-Eliz M, Llerena S, Pascasio JM, Turnes J, Torras X, Morillas RM, Llaneras J, Serra MA, Diago M, Fernández Rodriguez C, Ampuero J, Jorquera F, Simon MA, Arenas J, Navascues CA, Bañares R, Muñoz R, Albillos A, Mariño Z.

    Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.

    JOURNAL OF HEPATOLOGY . 66(6): 1138-1148. Nº de citas: 127

    [doi:10.1016/j.jhep.2017.01.028]

  • Rodríguez de Santiago E, Albillos Martínez A, López-Sanromán A.

    Infections in inflammatory bowel disease.

    MEDICINA CLINICA . 148(9): 415-423. Nº de citas: 5

    [doi:10.1016/j.medcli.2016.12.041]

  • Gisbert JP, Molina-Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, Castro-Fernández M, Cuadrado-Lavín A, Elizalde JI, Gene E, Gomollón F, Lanas Á, de Argila CM, Mearin F, Montoro M, Pérez-Aisa Á, Pérez-Trallero E, McNicholl AG.

    Erratum to IV Spanish Consensus Conference on Helicobacter pylori infection treatment [Gastroenterol Hepatol 39 (2016) 697-721].

    GASTROENTEROLOGIA Y HEPATOLOGIA . 40(5): 378-378.

    [doi:10.1016/j.gastrohep.2017.02.004]

  • Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljevic T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A, European FMT Working Group.

    European consensus conference on faecal microbiota transplantation in clinical practice.

    Gut . 66(4): 569-580. Nº de citas: 497

    [doi:10.1136/gutjnl-2016-313017]

  • Berzigotti A, Albillos A, Villanueva C, Genescá J, Ardevol A, Augustín S, Calleja JL, Bañares R, García-Pagán JC, Mesonero F, Bosch J, Ciberehd SportDiet Collaborative Group.

    Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.

    HEPATOLOGY . 65(4): 1293-1305. Nº de citas: 132

    [doi:10.1002/hep.28992]

  • Alonso S, Riveiro-Barciela M, Fernandez I, Rincón D, Real Y, Llerena S, Gea F, Olveira A, Fernandez-Carrillo C, Polo B, Carrión JA, Gómez A, Devesa MJ, Baliellas C, Castro Á, Ampuero J, Granados R, Pascasio JM, Rubín A, Salmeron J, Badia E, Planas JM, Lens S, Turnes J, Montero JL, Buti M, Esteban R, Fernández-Rodríguez CM.

    Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.

    JOURNAL OF VIRAL HEPATITIS . 24(4): 304-311. Nº de citas: 33

    [doi:10.1111/jvh.12648]